Loading page
Loading page
Loading substance route
This emerging substance has minimal human use documentation; conservative dose titration is advisable. Rapid tolerance develops with repeated administration, necessitating dose escalation to maintain equivalent effects; tolerance typically resets within 1–2 weeks of cessation.
Effects vary widely by individual, dose, and context.
The general head space of diphenidine is often described as particularly euphoric and clear headed in comparison to that of DXM and ketamine.
This substance does not enhance visual stimuli; instead it tends to degrade and decrease visual aptitude in a variety of ways.
The visual geometry of diphenidine can be described as very dark and bland when compared to that of ketamine or DXM and often consists of many tiny interlocking and woven lines. It does not extend beyond level 4 and can be comprehensively described as simplistic in complexity, algorithmic in style, synthetic in feel, unstructured in organization, dimly lit in lighting, multicoloured in scheme, glossy in shading, soft in edges, small in size, slow in speed, smooth in motion, equal in rounded and angular corners, immersive in depth and consistent in intensity.
At high dosages, diphenidine can produce a full range of high level hallucinatory states in a fashion that is less consistent and reproducible than that of many other commonly used psychedelics.
Classified as habit-forming with compulsive redosing reported as a notable cognitive effect. Addictive potential remains poorly characterized due to limited research, though anecdotal evidence suggests it should not be binged.
Fatal poisonings have been documented, though all reported cases involved polydrug use. One fatality was linked to a herbal incense product containing diphenidine alongside AB-CHMINACA and 5F-AMB. Another fatal case involved simultaneous use of three substituted cathinones, three benzodiazepines, and alcohol. No isolated diphenidine fatalities with established doses have been reported. The dosage curve has been described as particularly steep, suggesting a narrow margin between recreational and dangerous doses.
Diphenidine was originally synthesized in 1924 through a Bruylants reaction, a nitrile displacement method that would later prove instrumental in the discovery of phencyclidine over three decades later in 1956. Despite this early synthesis, the compound remained largely obscure for decades and did…
Diphenidine emerged on the grey market following the 2013 UK ban on arylcyclohexylamines. As a diarylethylamine rather than an arylcyclohexylamine, it was not initially covered by this scheduling and was reportedly available through research chemical vendors. Sources from this period described diphenidine as existing in a legal grey area, with the caveat that legal status could vary by jurisdiction and possession might still carry legal risk.
19 sources cited
